Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says

Johnson & Johnson Covid-19 vaccine is 66% effective in global trial, but 85% effective against severe disease, company says submitted by /u/Fitness_and_Finance
[link] [comments]

Comments

Post a Comment

Popular posts from this blog

Nadda reviews healthcare delivery mechanisms in Rajasthan, Maharashtra

The discussion centred on reinforcing public health infrastructure, improving patient-centric services, strengthening regulatory frameworks, and advancing India's commitment to eliminating tuberculosis as a public health challenge, the health ministry said in a statement. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/avQFOIc via gqrds
Read more

Women in India Report Higher Sleep Deprivation Than Men

The survey, conducted by Resmed, gathered insights from 30,000 people across 13 countries, including 5,000 respondents in India. The findings highlight a growing recognition of sleep as a health priority and underlined a persistent gaps in achieving consistent, quality rest. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/14OaF7t via gqrds
Read more

Capping MBBS seats by NMC deferred for academic years 2024-25, 2025-26: Nadda

The health minister was responding to a question on whether the government has noted concerns that the NMC's 2023 directive to cap MBBS seats at 100 per 10 lakh population in a state will adversely impact the southern states. from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/K3rdunz via gqrds
Read more